Malaysia Says Transshipment Suspected in Cases of Tainted Shrimp
Possible transshipment of shrimp claimed as from Malaysia could be behind a slew of import alerts from the Food and Drug Administration in recent years, Malaysia's Fisheries Department said in a Jan. 4 news release. The Malaysian agency issued the…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
statement in response to an article in The Star about the state of seafood from the country that noted that between 2009 and 2018, the FDA found illegal antibiotics among many shrimp shipments. “We suspect an element of transshipment, involving shrimp from foreign countries outside of our jurisdiction, that were imported and then re-exported to the United States,” the department said in its statement, according to an unofficial translation. The agency said “a total of 2,466 samples were taken for the period 2008 to date and analyzed at the Fisheries Biosecurity Laboratory which has been ISO certified and found that no antibiotic substances were detected and that all local livestock shrimp samples were not detected / negative in the presence of antibiotics.”